The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability

Peer review reports

Original Submission
13 Dec 2013	Submitted	Original manuscript
13 Dec 2013	Author responded	Author comments - emma weldon
23 Jan 2014	Reviewed	Reviewer Report - Wilhelm Schulte-Mattler
Resubmission - Version 2
13 Dec 2013	Submitted	Manuscript version 2
Publishing
31 Jan 2014	Editorially accepted
17 Feb 2014	Article published	10.1186/1745-6215-15-60

Back to article page